This fast track antibody is not yet fully characterized. It is subject to these terms and conditions

ab43152 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

ab43152 は 2 報の論文で使用されています。

  • Ying M  et al. Bortezomib sensitizes human acute myeloid leukemia cells to all-trans-retinoic acid-induced differentiation by modifying the RARa/STAT1 axis. Mol Cancer Ther 12:195-206 (2013). WB ; Human . PubMed: 23243061
  • Guo Y  et al. Blockade of the Ubiquitin Protease UBP43 Destabilizes Transcription Factor PML/RAR{alpha} and Inhibits the Growth of Acute Promyelocytic Leukemia. Cancer Res 70:9875-85 (2010). WB ; Human . PubMed: 20935222

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"